TAVR Update: Edwards Delays European Launch Of Sapien 3 Ultra; New Medtronic CoreValve Data

Edwards originally predicted the Sapien 3 Ultra transcatheter aortic valve would hit the European market this quarter, but the company is now pushing that back to later in 2018 to wait for data from a small single-arm multicenter trial in intermediate-risk patients. In other TAVR news, long-term data supporting Medtronic's CoreValve line of TAVR systems was featured at the recent American College of Cardiology meeting.